WRAP53β, survivin and p16(INK4a) expression as potential predictors of radiotherapy/chemoradiotherapy response in T2N0-T3N0 glottic laryngeal cancer

The current treatment recommendation for T2-3N0M0 glottic squamous cell carcinoma (SCC) in the Nordic countries comprises of radiotherapy (RT) and chemoradiotherapy (CRT). Tumor radiosensitivity varies and another option is primary surgical treatment, which underlines the need for predictive markers...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiefenböck-Hansson, Katharina, Haapaniemi, Aaro, Farnebo, Lovisa, Palmgren, Björn, Tarkkanen, Jussi, Farnebo, Marianne, Munck-Wikland, Eva, Mäkitie, Antti, Garvin, Stina, Roberg, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652956/
https://www.ncbi.nlm.nih.gov/pubmed/28849066
http://dx.doi.org/10.3892/or.2017.5898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652956/
https://www.ncbi.nlm.nih.gov/pubmed/28849066
http://dx.doi.org/10.3892/or.2017.5898

Ejemplares similares